Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Tachibana, S. Sonobe, U. Fujii, Y. Fuchimoto, M. Shiojiri, K. Inoue, N. Nakanishi, T. Moritaka, Y. Yamaji, S. Tada, T. Kamei, N. Ueda (Matsuyama, Kannonji, Marugame, Takamatsu, Japan). Analysis of atherosclerosis in patients with chronic obstructive pulmonary disease by carotid ultrasonography. Eur Respir J 2011; 38: Suppl. 55, 4060

Member's Comments

No comment yet.

Related content which might interest you: The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The incidence of venous insufficiency in patients with chronic obstructive pulmonary disease evaluated by color Doppler ultrasonography Source: Eur Respir J 2005; 26: Suppl. 49, 510s Year: 2005 Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD Source: Eur Respir J 2001; 17: 350-355 Year: 2001 The usefulness of pedometry in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006 Predominant emphysema phenotype in chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 450-454 Year: 2003 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Quantitative estimation of lung perfusion scintigraphy in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging Year: 2012 Myocardial injuries in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Analysis of mortality in Japanese patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010 Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Microalbuminuria in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Microalbuminuria in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 256s Year: 2002